Investigational Site Number : 1560013

Shenyang 110022

1 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma Recurrent, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes — Recruiting now
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling